๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Polycythemia Vera

MPNdpoint. Single-center, Retrospective, Prospective Study of the Outcome of Patients With Philadelphia-negative Chronic Myeloproliferative Neoplasms NCT07863466n/a1 site๐Ÿ“ Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: biologic sample preservation procedure, cytology specimen collection procedure Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients NCT04655092Phase 36 sites๐Ÿ“ Toon-shi๐Ÿ“ Tsu๐Ÿ“ Suita-shi PharmaEssentia Japan K.K. ยท Tests: P1101 (Ropeginterferon alfa-2b) Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes NCT06361641NA3 sites๐Ÿ“ Angers๐Ÿ“ Cholet๐Ÿ“ Saumur University Hospital, Angers ยท Tests: Monocytes signatures in myeloproliferative neoplasms at diagnosis Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera NCT06516406n/a26 sites๐Ÿ“ Cosenza๐Ÿ“ Reggio Calabria๐Ÿ“ Naples IRCCS Azienda Ospedaliero-Universitaria di Bologna A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera NCT06752746Phase 16 sites๐Ÿ“ Zhengzhou๐Ÿ“ Wuhan๐Ÿ“ Nanchang Mabwell (Shanghai) Bioscience Co., Ltd. ยท Tests: 9MW3011 Therapeutic RSK1 Targeting in Myeloid Malignancies NCT07379125Phase 11 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: PMD-026 Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia NCT05320198Phase 1, Phase 235 sites๐Ÿ“ Gilbert๐Ÿ“ Duarte๐Ÿ“ Irvine Disc Medicine, Inc ยท Tests: DISC-0974 Safety and Tolerability of ZE74-0282 in Healthy Volunteers NCT07527221Phase 11 site๐Ÿ“ Randwick Eilean Therapeutics AU Pty Ltd ยท Tests: ZE74-0282-0001 or placebo Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly NCT06743035n/a1 site๐Ÿ“ Hanover iOMEDICO AG A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) NCT06351631Phase 321 sites๐Ÿ“ Ann Arbor๐Ÿ“ Durham๐Ÿ“ Columbus Merck Sharp & Dohme LLC ยท Tests: Bomedemstat A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF) NCT07357727Phase 3148 sites๐Ÿ“ Denver๐Ÿ“ New Haven๐Ÿ“ Fort Myers Novartis Pharmaceuticals ยท Tests: Pelabresib, Ruxolitinib, Placebo An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms NCT05123365Phase 1, Phase 22 sites๐Ÿ“ Irvine๐Ÿ“ Orange University of California, Irvine ยท Tests: N-Acetylcysteine A Study of GLB-001 in Patients With Myeloid Malignancies NCT06378437Phase 114 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Chongqing Hangzhou GluBio Pharmaceutical Co., Ltd. ยท Tests: GLB-001 Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms NCT04282187Phase 21 site๐Ÿ“ Seattle University of Washington ยท Tests: Decitabine, Ruxolitinib, Fedratinib, Questionnaire Administration, Pacritinib MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) NCT07362225n/a2 sites๐Ÿ“ Chicago๐Ÿ“ New York MPN Research Foundation Registry of Older Patients With Cancer NCT01137825n/a7 sites๐Ÿ“ Boone๐Ÿ“ Chapel Hill๐Ÿ“ Greenville UNC Lineberger Comprehensive Cancer Center Pegylated Interferon ฮฑ-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV NCT05870475Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Ruxolitinib, Pegylated interferon ฮฑ-2b A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms NCT07469891Phase 122 sites๐Ÿ“ Los Angeles๐Ÿ“ Sacramento๐Ÿ“ Denver Prelude Therapeutics Incorporated ยท Tests: PRT12396 Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis. NCT05440838n/a6 sites๐Ÿ“ Angers๐Ÿ“ Brest๐Ÿ“ Nantes University Hospital, Angers ยท Tests: Next-generation sequencing A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV NCT07445893NA1 site๐Ÿ“ Beijing Duan Minghui ยท Tests: Gecacitinib Hydrochloride Tablets๏ผ›Pegylated interferon alfa-2b Study of INCA036978 in Participants With Myeloproliferative Neoplasms NCT07441694Phase 154 sites๐Ÿ“ Birmingham๐Ÿ“ Irvine๐Ÿ“ Los Angeles Incyte Corporation ยท Tests: INCA036978, Standard disease-directed therapy INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV) NCT07429266Phase 338 sites๐Ÿ“ Orange๐Ÿ“ Miami๐Ÿ“ Plantation Ono Pharmaceutical Co., Ltd. ยท Tests: Sapablursen, Placebo Two Step Haplo With Radiation Conditioning NCT05031897Phase 21 site๐Ÿ“ Philadephia Thomas Jefferson University ยท Tests: Fludarabine, Total-Body Irradiation, Donor Lymphocyte Infusion, Cyclophosphamide, Tacrolimus Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera NCT07232290Phase 21 site๐Ÿ“ Tianjin Chengdu Zenitar Biomedical Technology Co., Ltd ยท Tests: Flonoltinib 75mg, Flonoltinib 100mg, Flonoltinib 125mg, Extended Phase Dose Group MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial NCT06541249Phase 21 site๐Ÿ“ New York Icahn School of Medicine at Mount Sinai ยท Tests: Methotrexate (MTX) Myeloproliferative Neoplasms (MPNs) Patient Registry NCT02760238n/a1 site๐Ÿ“ Toronto University Health Network, Toronto ยท Tests: Observational A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis NCT05714072Phase 17 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Ruxolitinib, Abemaciclib Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV) NCT07012109Phase 11 site๐Ÿ“ Tianjin BeBetter Med Inc ยท Tests: BEBT-507 Injection AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms NCT05198960Phase 342 sites๐Ÿ“ Angers๐Ÿ“ Annecy๐Ÿ“ Argenteuil University Hospital, Brest ยท Tests: Direct Oral Anticoagulants, Low-dose aspirin
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy